Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectGlobal Bioanalytical Testing Services Market
The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.
Liquid Handling: Technologies and Global Markets
The global liquid handling technologies market reached $4.2 billion in 2022, should reach $4.5 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2023-2028.
Global Next-Generation Sequencing on Drug Development Market
The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.
Artificial Blood: Global Markets to 2028
The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.
RNAi Drug Delivery: Technologies and Global Markets
The global nucleic acid drug delivery market should reach $2.7 billion by 2028 from $1.1 billion in 2023 at a compound annual growth rate (CAGR) of 20.5% for the forecast period of 2023 to 2028.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Mar...
The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.
Cell and Gene Therapy Manufacturing Services Market
The global cell and gene therapy manufacturing services market reached $4.9 billion in 2022, should reach $5.7 billion by 2023 and $11.8 billion by 2028 with a compound annual growth rate (CAGR) of 15.7% during the forecast period of 2023-2028.
Commercial Amino Acids
The global amino acids market was $28.6 billion in 2022 and it should reach $38.8 billion by 2028 from $30.1 billion in 2023 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2023 to 2028.
Nanoparticles in Biotechnology, Drug Development and Drug Deliver...
The global nanoparticles in biotechnology, drug development, and drug delivery systems market should reach $156.8 billion by 2028 from $102.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.8% for the forecast period of 2023 to 2028.
Oncology Biomarkers: Global Markets
The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.
Clinical Diagnostics: Global Markets
The global market for clinical diagnostics reached $67.8 billion in 2022. The market is estimated to grow from $73.1 billion in 2023 to reach $103.4 billion by 2028, at a compound annual growth rate (CAGR) of 7.2% from 2023 through 2028.
Microbial Products: Technologies, Applications and Global Markets
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics (CDx) is estimated to increase from $6.4 billion in 2022 to reach $13.0 billion by 2027, at a compound annual growth rate (CAGR) of 15.3% from 2022 through 2027.
Next-Generation Cancer Diagnostics: Technologies and Global Marke...
The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.
Central Nervous System (CNS) Biomarkers: Technologies and Global ...
The global central nervous system (CNS) biomarkers market should reach $9.5 billion by 2027 from $5.7 billion in 2022 at a compound annual growth rate (CAGR) of 10.8% for the forecast period of 2022 to 2027.
Immunoglobulins: Global Market Outlook
The goal is to furnish an up-to-date analysis of the global immunoglobulins market and future opportunities in the market. The report provides an overview of the global immunoglobulins market and examines market trends. It also highlights major trends and challenges that affect the market and the vendor landscape. The scope of the study encompasses the current and forecast markets for normal and hyper immunoglobulins , includes market drivers and restraints, the competitive landscape, and current and emerging technologies. It also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.
Global Markets and Technologies for Cell and Tissue Analysis
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Global Markets for Bioengineered Protein Drugs
The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Global Market for Stem Cells
The global stem cell market reached $32.1 billion in 2022 and should reach $65.6 billion by 2027, with a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2022-2027.
Glycobiology: Global Markets for Diagnostics and Therapeutics
The global glycobiology market should reach $5.3 billion by 2027 from $3.2 billion in 2022 at a compound annual growth rate (CAGR) of 11.1% for the forecast period of 2022 to 2027.
Global Spatial Genomics and Transcriptomics Market
The global market for spatial genomics and transcriptomics is estimated to increase from $1.5 billion in 2022 to reach $2.5 billion by 2027, at a compound annual growth rate (CAGR) of 10.8% from 2022 through 2027.
Sample Preparation in Genomics, Proteomics, and Epigenomics: Glob...
The global sample preparation in genomics, proteomics, and epigenomics market should reach $7.4 billion by 2027 from $5.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.4% for the forecast period of 2022 to 2027.
High-Performance Liquid Chromatography (HPLC): Global Market
The global high-performance liquid chromatography (HPLC) market should reach $5.7 billion by 2027 from $4.5 billion in 2022 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2022 to 2027.
Global Markets for Microbiology Technology, Equipment and Consuma...
The global microbiological technology, equipment and consumables market should reach $8.5 billion by 2027 from $5.6 billion in 2022 at a compound annual growth rate (CAGR) of 8.9% for the forecast period of 2022 to 2027.
Biologics Development and Manufacturing Testing: Technologies and...
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Choose your License
Biologics Contract Development and Manufacturing Organizations (CDMO) Market
- An up-to-date overview and industry analysis of the global markets for biologics contract development and manufacturing organizations (CDMO)
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for biologics CDMO market in USD million values, and their corresponding market share analysis based on the product type, cell line type, and geographic region
- In-depth information (facts and figures) concerning the market growth drivers, opportunities and challenges, prospects, technologies, regulatory scenarios, and the impact of macroeconomic variables on biologics CDMO marketplace
- Discussion of ESG developments in global CDMO services market, with emphasis on importance of ESG, consumer attitudes, risks and opportunity assessment, and ESG followed practices
- Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Market outlook and opportunity assessment of the industry structure for biologics CDMO services, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
- Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
- Analysis of the company competitive landscape based on recent developments, key financials, and operational integration
- Descriptive company profiles of the major market players
Bioinformatics: Technologies and Global Markets
- An up-to-date overview and industry analysis of the global bioinformatics market
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for global bioinformatics market in USD million values, and corresponding market share analysis based on the type of sequencing services and platforms, application, solution, end user, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
- Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
- Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
- Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
- A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
- Patent analysis covering significant allotments of recent patent grants across each major category
- Profile descriptions of the leading market players
Agricultural Biotechnology: Emerging Technologies and Global Markets
- An overview of the global markets for agricultural biotechnology and other emerging technologies
- Estimation of the market size and analyses of global market trends with data from 2022, 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Description of key agricultural biotechnology tools such as next generation DNA sequencing, biochips, RNA interference, synthetic biology tools and genome editing tools, and assaying their role in enhancing the marketplace
- Assessment of market opportunities for biotechnology tools, genomic-enabled products, and biotech seeds
- Key merger and acquisitions, joint ventures, and alliances within the large biotechnology companies, allowing them to participate in the upside of new genomics technologies that will enhance their breeding, seed development, and biologics programs
- Company profiles of market leading participants
Digital Polymerase Chain Reaction (PCR) Technology: Global Markets
- An up-to-date overview and industry analysis of the global market for digital polymerase chain reaction (PCR) technology
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for digital PCR technologies market, and corresponding market share analysis based on product, technology type, application, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Discussion of industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on manufacturers, suppliers, and major types of end-users
- Analysis of the market growth opportunities with a holistic review of Porter’s five forces analysis and PESTLE analysis considering both micro- and macro environmental factors prevailing in marketplace
- Understanding of the importance of ESG in the digital PCR technology market, consumer attitudes, risks and opportunity assessment, and ESG followed practices by manufacturers and service providers
- A look at the major vendors in the global market for digital PCR technologies, and analyze the structure of the industry (e.g., market shares, concentration, and recent M&A activities)
- Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
- Detailed company profiles of the leading market players
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- An overview of the global market for emerging clinical applications of the next-generation sequencing
- Estimation of the market size and analyses of global market trends with data from 2022, 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the current and future market potential and quantification of the market by disease indication, test complexity, test purpose, application, and geographic region
- Discussion on market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenario, and penetration of NGS-based diagnostics and technologies within the industry
- Coverage of genome mapping programs, discussion on technological advancements and innovations in sequencing platforms, and information on Ion Torrent Genexus System launched by Thermo Fisher Scientific and Magnis NGS Prep System launched by Agilent Technologies, Inc.
- Description of NGS-oriented tests such as non-invasive prenatal testing (NIPT), and pre-implantation genetic testing (PGT) and discussion on their advantages
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Induced Pluripotent Stem Cells: Global Markets
- An overview of the global market for induced pluripotent stem cells
- Estimation of the market size and analyses of market trends, with data from 2022, estimates for 2023 and projection of CAGR through 2028
- Analysis of the market's dynamics, including growth drivers, inhibitors, and opportunities, and insights into the regulatory environments impacting the market
- Assessment of recent or ongoing research and development activities in the iPSCs segment, highlights of the new developments and the recent pipeline products
- Information on the latest research activities, emerging technologies, and clinical trials
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry
Global Sleeping Sickness Market
- An overview and up-to-date analysis of the global sleeping sickness market
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global sleeping sickness market in USD millions, and corresponding market share analysis based on diagnosis type, treatment modality, and geographic region
- In-depth information (facts and figures) pertaining to the market growth drivers, opportunities and challenges, upcoming technologies, future prospects, and regulatory scenarios; and the impacts of COVID-19 and the Russia-Ukraine war on the market
- Discussion of the importance of ESG in sleeping sickness market, including consumer attitudes, impact of ESG factors on company performance, and the ESG practices followed
- Identification of the major stakeholders, and analysis of their company competitive landscape based on news/developments, company financials, competitive strategies, and operational integration
- Profiles of the leading market players
Global Markets for Research Antibodies
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2023 and 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Polymerase Chain Reaction (PCR) Technologies and Global Markets
- An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technology, application, and region
- In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
- Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
- Discussion of sustainability trends and factors in emerging materials in the aerospace industry, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
- Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
- Profiles of the leading global players